CPBIO Holding Company Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CAIHF research report →
Price Chart
About the company
CPBIO Holding Company Limited produces and distributes chlortetracycline (CTC) and related goods. Its extensive international reach covers Mainland China, the Asia Pacific region, the Americas, and Europe. The company's operations are divided into two distinct divisions: Biochemical and Industrial.
- CEO
- Chawalit Na Muangtoun
- IPO
- 2023
- Employees
- 900
- HQ
- Hong Kong, HK
Get TickerSpark's AI analysis on CAIHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $270.48M
- P/E
- 11.93
- PEG
- -0.37
- P/S
- 0.54
- P/B
- 0.82
- EV/EBITDA
- 7.60
- Div Yield
- 0.00%
- Gross Margin
- 16.38%
- Op Margin
- 6.48%
- Net Margin
- 4.73%
- ROE
- 7.14%
- ROIC
- 5.21%
Latest fiscal year · YoY change
- Revenue
- $536.71M+73.7%
- Gross Profit
- $77.55M+57.8%
- Op Income
- $38.95M
- Net Income
- $32.10M+186.3%
- EPS
- $0.13+193.5%
- OCF Growth
- +137.2%
- FCF Growth
- +4789.8%
- 52W High
- $1.07
- 52W Low
- $0.00
- 50D MA
- $1.07
- 200D MA
- $0.56
- Beta
- 4.06
- RSI (14)
- 100
- Avg Volume
- 8
No earnings-call transcripts are available for CAIHF yet.
- Free Float
- 25.4%
- Shares Outstanding
- 253.33M
- Float Shares
- 64.37M
Our CAIHF coverage
Recent articles, reports, and earnings notes.
No research on CAIHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CAIHF report →